Log in to save to my catalogue

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8522799

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

About this item

Full title

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2021-12, Vol.385 (24), p.e83

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a test-negative, case–control study involving more than 900,000 participants in Qatar, vaccine effectiveness peaked at 77.5% in the first month after the second dose. The effectiveness fell thereafter to as low as 20% in months 5 through 7 after vaccination, but protection against serious Covid-19 remained greater than 90% for at least 6 months.

Alternative Titles

Full title

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8522799

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8522799

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2114114

How to access this item